← Back to patent-cliff list
LTM-1201L
Tier C — Watch / tradeLTM-1201L
The Brigham and Women's Hospital
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：Obstructive sleep apnoea syndrome
Regional status
US
No progress
2018-10-30
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of LTM-1201L?
Approved indications include: Obstructive sleep apnoea syndrome.
When does the LTM-1201L patent expire?
No public expiry year is available for LTM-1201L yet; this page updates once verified.
How do I get a quote for LTM-1201L intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08